Significant Ownership of B Group, Inc.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for B Group, Inc. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Dallas, TX
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow B Group, Inc. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from B Group, Inc.
Significant Ownership of B Group, Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NRXP | NRx Pharmaceuticals, Inc. | Common Stock, $0.001 par value | 13% | $8,820,000 | 3,000,000 | The B Group, Inc. | 18 Aug 2025 |
Schedules 13D/G Reported by B Group, Inc.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.